logo
  

Elanco Animal Health Gets EU Approval For Acquisition Of Bayer AG's Animal Health Business

Elanco Animal Health Inc. (ELAN) Monday announced that the European Commission has approved its pending acquisition of Bayer AG's animal health business.

The company expects to close the deal by August 3, 2020.

"Approval from the European Commission is an important milestone toward the completion of our acquisition of Bayer Animal Health," said Jeff Simmons, president and CEO of Elanco.

Elanco previously announced divestiture agreements in the range of $120 million to $140 million of revenue to help advance the needed regulatory reviews

The worldwide rights for Osurnia, a treatment for otitis externa in dogs, will be sold to Dechra Pharmaceuticals, the worldwide rights for Vecoxan, used for prevention and treatment of coccidiosis in calves and lambs will be sold to Merck Animal Health and European Economic Area and UK rights to the Drontal and Profender product families and related pipeline assets from Bayer Animal Health will be sold to Vetoquinol SA, the European Commission said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
When Can We Expect Starlink to Go Public? This question got an answer from Tesla and SpaceX CEO Elon Musk, who said he will only publicly list SpaceX's satellite internet service Starlink when its revenue is more predictable. Musk was responding to a users tweet, "Any thoughts on Starlink IPO we would love to invest in the future. Any thoughts on first dibs for Tesla retail investors?" John David McAfee, who founded the antivirus software company McAfee Associates, has been found dead in a prison cell in Spain shortly after a Spanish court agreed to extradite him to the US to face tax evasion charges, multiple reports said. He was arrested in Spain in October 2020 after being accused of failing to file tax returns for four years. While reporting financial results for the first quarter of fiscal 2022 on Thursday, drugstore chain Rite Aid Corp. (RAD) initiated its adjusted loss and total revenue guidance for the full-year 2022, below analysts' estimates. For fiscal 2022, the company now projects an adjusted loss in a range...
Follow RTT